Firstly hello everyone.
I was given my active diagnosis of Relapsing MS in December, then there was mention of a trial, today I received an email with the details.
Info of the trial drug is on the https://www.mssociety.org.uk/ms-research/treatments-in-the-pipeline/ocrelizumab
My question to everyone is… Is it worth risking a trial when the alternative drug in the trial is a weak first line compared to the alternative known non trial drug?
My appointment is on Friday so responses would help please.